9th Aug 2019 – Global Zika
Virus Testing Market was valued at USD 131.9 million in 2016 and is
estimated to grow significantly due to the growing demand for diagnostics from
different parts of the world. Zika Virus is a disease by mosquitos that targets
pregnant ladies especially the fetus. In 2016, there was a sudden outburst of
Zika Virus, which led to a massive demand for point-of-care testing diagnostic
tests.
The diagnostic test is not location
specific with no special requirements for special laboratory setup. The
point-of-care test comprises RT-PCR, serology IgG/IgM Antibody detection, ELISA
and with no laboratory organization. These tests are undertaken in riskier
surroundings, which display harsh symptoms of Zika Virus like fever in
pregnancy along with rashes, muscle pain or joint pain and conjunctivitis. The
disease can be transferred form one individual to another either by sexual
contact or from mother to fetus while pregnancy. The disease prevention
planning and funding therapeutic and is expected to boost the market growth in
the coming years with a CAGR of 7.6%.
No proper vaccination has been found
against Zika Virus till date in spite of the extensive ongoing research; hence
to relieve the symptoms care and comfort is the only way to deal with this
situation. Zika Virus detection kit is available for qualitative tests that are
helpful in detecting RNA of Zika Virus from the body samples like plasma, urine
and serum. After detection of Zika Virus is in the body, antibodies
Immunoglobulin M (IgM) are developed against the virus. The Zika Virus RNA
detection test and the positive serum test for Immunoglobulin M (IgM) are
performed to check and ascertain the presence of Zika Virus in the body.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/zika-virus-testing-market/request-sample
The research and development activities
have been increased by the leading market players due to the government
initiatives for the emergence of enhanced tests for detecting Zika Virus. The
speedy growing prevalence of Zika Virus testing infection, increasing awareness
regarding early detection and rising efforts by the manufacturers to introduce
Zika Virus detection tests are predicted to drive the market growth. Moreover,
the slow speed of adoption of modern technologies & lack of awareness in
emerging nations and enormous costs of branded test kits are estimated to bring
obstacles in the growth of Zika Virus Testing Market in the near future. Also,
incorrect results from defective diagnostic techniques can affect the Zika
Virus Testing Market.
Currently, the Zika Virus detection is
done in view of clinical manifestations. The serological devices and molecular
detection are also important. Since the segmentation of this virus is
difficult, NASBA, LFAs, and LAMP help in detecting and confirming reason behind
fever. These new techniques have supported in faster and accurate detection of
the virus.
The market is categorized on the basis
of test type, end user and geography. On the basis of test type, the market is
divided into serological tests and molecular diagnostic tests which is also
called as nucleic acid amplification tests. The commonly used test is molecular
diagnosis tests. It is (RT-PCR) Reverse Transcriptase Polymerase Chain Reaction
that detects the existence of the Zika virus in human serum. The serological
tests are dependent on the detection of IgM and IgG antibodies in the human’s
serum by ELISA-based tests. On the basis of end-user, the Zika Virus Testing
Market can be divided into diagnostic & pathological laboratories, contract
research organizations, hospitals, and academic & research institutes.
Geographically, the market is segmented
into Latin America, North America, Asia Pacific, Europe and Middle East &
Africa. North America is expected to dominate the market largely in the coming
years due to the speedy growth of Zika virus in the region. After North
America, Europe is expected to contribute the Zika Virus Testing Market at a
significant pace. The Zika Virus Testing Market in Asia Pacific is predicted to
grow in the coming years owing to the increasing awareness of Zika Virus and
the emerging healthcare industry in the area. The prominent players in the Zika
Virus Testing Industry are ARUP Laboratories, Luminex Corporation, Hologic,
Siemens Healthcare Diagnostics and Roche Molecular Systems.
For
More Details, Visit @ http://www.millioninsights.com
No comments:
Post a Comment